Anti‐N and anti‐Doa immunoglobulin G alloantibody–mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC‐201: case report and review of the literature
Sign Up to like & getrecommendations! Published in 2019 at "Transfusion"
DOI: 10.1111/trf.15198
Abstract: Delayed hemolytic transfusion reaction (DHTR) with hyperhemolysis is a potentially fatal complication resulting from alloimmunization that can cause severe hemolysis of both transfused and intrinsic red blood cells (RBCs). Patients with sickle cell disease often… read more here.
Keywords: hemolytic transfusion; transfusion reaction; transfusion; cell disease ... See more keywords
Rates of delayed hemolytic transfusion reactions observed in a trauma center
Sign Up to like & getrecommendations! Published in 2021 at "Transfusion"
DOI: 10.1111/trf.16433
Abstract: Delayed hemolytic transfusion reactions (DHTRs) are reported to be rare occurrences but may be more frequently observed in the trauma setting where patients are heavily transfused, followed over long inpatient admissions, and have frequent subsequent… read more here.
Keywords: hemolytic transfusion; rates delayed; transfusion; delayed hemolytic ... See more keywords
Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy
Sign Up to like & getrecommendations! Published in 2020 at "Haematologica"
DOI: 10.3324/haematol.2020.253229
Abstract: Citation: Elizabeth F. Stone, Scott T. Avecilla, David L. Wuest, Christine Lomas-Francis, Connie M. Westhoff, David L. Diuguid, Michel Sadelain, Farid Boulad, and Patricia A. Shi. Severe delayed hemolytic transfusion reaction due to anti-Fy3 in… read more here.
Keywords: hemolytic transfusion; transfusion reaction; severe delayed; reaction due ... See more keywords